BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

990 related articles for article (PubMed ID: 22425883)

  • 21. Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement.
    Tubach F; Ravaud P; Baron G; Falissard B; Logeart I; Bellamy N; Bombardier C; Felson D; Hochberg M; van der Heijde D; Dougados M
    Ann Rheum Dis; 2005 Jan; 64(1):29-33. PubMed ID: 15208174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Efficacy, Tolerability, and Joint Safety of Fasinumab in Osteoarthritis Pain: A Phase IIb/III Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Dakin P; DiMartino SJ; Gao H; Maloney J; Kivitz AJ; Schnitzer TJ; Stahl N; Yancopoulos GD; Geba GP
    Arthritis Rheumatol; 2019 Nov; 71(11):1824-1834. PubMed ID: 31207169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacement.
    Gossec L; Paternotte S; Maillefert JF; Combescure C; Conaghan PG; Davis AM; Gunther KP; Hawker G; Hochberg M; Katz JN; Kloppenburg M; Lim K; Lohmander LS; Mahomed NN; March L; Pavelka K; Punzi L; Roos EM; Sanchez-Riera L; Singh JA; Suarez-Almazor ME; Dougados M;
    Osteoarthritis Cartilage; 2011 Feb; 19(2):147-54. PubMed ID: 21044689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis.
    Ehrich EW; Davies GM; Watson DJ; Bolognese JA; Seidenberg BC; Bellamy N
    J Rheumatol; 2000 Nov; 27(11):2635-41. PubMed ID: 11093446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitivity to Change of a Computer Adaptive Testing Instrument for Outcome Measurement After Hip and Knee Arthroplasty and Periacetabular Osteotomy.
    McDonough CM; Stoiber E; Tomek IM; Ni P; Kim YJ; Tian F; Jette AM
    J Orthop Sports Phys Ther; 2016 Sep; 46(9):756-67. PubMed ID: 27494055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment outcomes of a Numeric Rating Scale (NRS)-guided pharmacological pain management strategy in symptomatic knee and hip osteoarthritis in daily clinical practice.
    Snijders GF; van den Ende CH; van den Bemt BJ; van Riel PL; van den Hoogen FH; den Broeder AA;
    Clin Exp Rheumatol; 2012; 30(2):164-70. PubMed ID: 22325619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee: A Randomized Clinical Trial.
    Schnitzer TJ; Easton R; Pang S; Levinson DJ; Pixton G; Viktrup L; Davignon I; Brown MT; West CR; Verburg KM
    JAMA; 2019 Jul; 322(1):37-48. PubMed ID: 31265100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Onset and durability of pain relief in knee osteoarthritis: Pooled results from two placebo trials of naproxen/esomeprazole combination and celecoxib.
    Holt RJ; Fort JG; Grahn AY; Kent JD; Bello AE
    Phys Sportsmed; 2015 Jul; 43(3):200-12. PubMed ID: 26313454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fatigue in knee and hip osteoarthritis: the role of pain and physical function.
    Snijders GF; van den Ende CH; Fransen J; van Riel PL; Stukstette MJ; Defoort KC; Arts-Sanders MA; van den Hoogen FH; den Broeder AA;
    Rheumatology (Oxford); 2011 Oct; 50(10):1894-900. PubMed ID: 21750001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Responsiveness and interpretability of the pain subscale of the Knee and Hip Osteoarthritis Outcome Scale (KOOS and HOOS) in osteoarthritis patients according to COSMIN guidelines.
    Rienstra W; Stevens M; Blikman T; Bulstra SK; van den Akker-Scheek I
    PLoS One; 2023; 18(11):e0293760. PubMed ID: 37971978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of E-OA-07 in moderate to severe symptoms of osteoarthritis: a double-blind randomized placebo-controlled study.
    Kulkarni MP; Shakeel A; Shinde BS; Rosenbloom RA
    Am J Ther; 2011; 18(2):170-7. PubMed ID: 21317618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Individualising the Western Ontario and McMaster Universities osteoarthritis index (WOMAC) function subscale: incorporating patient priorities for improvement to measure functional impairment in hip or knee osteoarthritis.
    Seror R; Tubach F; Baron G; Falissard B; Logeart I; Dougados M; Ravaud P
    Ann Rheum Dis; 2008 Apr; 67(4):494-9. PubMed ID: 17704063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Responsiveness of the WOMAC osteoarthritis index as compared with the SF-36 in patients with osteoarthritis of the legs undergoing a comprehensive rehabilitation intervention.
    Angst F; Aeschlimann A; Steiner W; Stucki G
    Ann Rheum Dis; 2001 Sep; 60(9):834-40. PubMed ID: 11502609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Superior responsiveness of the pain and function sections of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) as compared to the Lequesne-Algofunctional Index in patients with osteoarthritis of the lower extremities.
    Theiler R; Sangha O; Schaeren S; Michel BA; Tyndall A; Dick W; Stucki G
    Osteoarthritis Cartilage; 1999 Nov; 7(6):515-9. PubMed ID: 10558848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double blind, randomized, placebo controlled study to evaluate the efficacy of erythromycin in patients with knee effusion due to osteoarthritis.
    Sadreddini S; Noshad H; Molaeefard M; Moloudi R; Ardalan MR; Ghojazadeh M
    Int J Rheum Dis; 2009 Apr; 12(1):44-51. PubMed ID: 20374316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The factor subdimensions of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) help to specify hip and knee osteoarthritis. a prospective evaluation and validation study.
    Angst F; Ewert T; Lehmann S; Aeschlimann A; Stucki G
    J Rheumatol; 2005 Jul; 32(7):1324-30. PubMed ID: 15996072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immediate efficacy of neuromuscular exercise in patients with severe osteoarthritis of the hip or knee: a secondary analysis from a randomized controlled trial.
    Villadsen A; Overgaard S; Holsgaard-Larsen A; Christensen R; Roos EM
    J Rheumatol; 2014 Jul; 41(7):1385-94. PubMed ID: 24931956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state.
    Tubach F; Ravaud P; Baron G; Falissard B; Logeart I; Bellamy N; Bombardier C; Felson D; Hochberg M; van der Heijde D; Dougados M
    Ann Rheum Dis; 2005 Jan; 64(1):34-7. PubMed ID: 15130902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The IPSO study: ibuprofen, paracetamol study in osteoarthritis. A randomised comparative clinical study comparing the efficacy and safety of ibuprofen and paracetamol analgesic treatment of osteoarthritis of the knee or hip.
    Boureau F; Schneid H; Zeghari N; Wall R; Bourgeois P
    Ann Rheum Dis; 2004 Sep; 63(9):1028-34. PubMed ID: 15308513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of celecoxib versus ibuprofen for the treatment of patients with osteoarthritis of the knee: A randomized double-blind, non-inferiority trial.
    Gordo AC; Walker C; Armada B; Zhou D
    J Int Med Res; 2017 Feb; 45(1):59-74. PubMed ID: 28222627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.